Wesley Gin Nung Kong, MD
Urology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 7 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
31 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kong’s office at (650) 962-4321 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Aetna Medicare Enhanced (HMO-POS) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced Extra (HMO-POS) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A81674 · Current
Licensed to practise in California · since 2003 · expires 2028-12-31 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$542,522
Medicare paid this office $542,522 for 674 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 477 | $126,276 | $117 |
| Botox | 43 | $63,502 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 43 | $37,852 | $382 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 89 | $33,951 | $377 |
| Insertion of lower leg neurostimulator electrode | 32 | $29,020 | $119 |
See all 30 services
| Return visit (30+ min) | 477 | $126,276 | $117 |
| Botox | 43 | $63,502 | None |
| Exam with injections of chemical for destruction of bladder using an endoscope | 43 | $37,852 | $382 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 89 | $33,951 | $377 |
| Insertion of lower leg neurostimulator electrode | 32 | $29,020 | $119 |
| Diagnostic exam of bladder and urethra using an endoscope | 92 | $26,679 | $245 |
| Short return visit (20+ min) | 262 | $26,203 | $77 |
| Long return visit (40+ min) | 115 | $22,623 | $165 |
| New patient visit (45+ min) | 104 | $15,083 | $145 |
| Insertion of device into abdomen with pressure and urine flow rate study | 66 | $13,145 | $199 |
| Complete ultrasound scan behind abdominal cavity | 90 | $11,376 | $107 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 444 | $11,087 | $15 |
| Assessment of muscle signal of pelvic nerves | 61 | $8,780 | $144 |
| Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies | 11 | $5,440 | $209 |
| Limited ultrasound scan of pelvis | 92 | $4,998 | $46 |
| Ultrasound measurement of bladder capacity after voiding | 248 | $4,894 | $12 |
| Injection of implant material beneath lining of bladder and/or urethra using an endoscope | 11 | $4,786 | $368 |
| Complicated insertion of bladder tube | 13 | $3,387 | $147 |
| Biopsy of prostate gland | 11 | $2,696 | $225 |
| Simple insertion of temporary bladder tube | 24 | $2,685 | $62 |
| Ultrasound scan of pelvic region through rectum | 15 | $2,381 | $149 |
| New patient visit (60+ min) | 11 | $2,099 | $191 |
| New patient visit (30+ min) | 24 | $1,908 | $79 |
| Simple bladder irrigation and/or instillation | 21 | $1,536 | $67 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $1,235 | $21 |
| Injection of drug or substance under skin or into muscle | 26 | $1,147 | $13 |
| Electronic assessment of bladder emptying | 110 | $979 | $8 |
| Urinalysis, manual test | 157 | $696 | $3 |
| Manual urinalysis test with examination using microscope, automated | 88 | $293 | $3 |
| Injection, ceftriaxone sodium, per 250 mg | 13 | $15 | None |
Procedures Medicare counted
| Prostate resection | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
674 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 24% · Women 52% · Also on Medicaid 12% · Health risk score 1.22. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Coronary heart disease 35% · Diabetes 31% · Chronic kidney disease 24% · Cancer 22% · Atrial fibrillation 21% · Depression 21% · Heart failure 17% · COPD 12% · Stroke 11% · Dementia 10%.
The office billed $2,176,849, Medicare allowed $703,131 and paid $542,522; for 38,665 services of 121 kinds; $92,549 of it was for drugs given in the office and $449,973 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 674 | 38,665 | 78 | 1.22 | $2,176,849 | $542,522 |
| 2023 | 693 | 34,969 | 78 | 1.16 | $1,389,109 | $502,994 |
| 2022 | 654 | 29,763 | 78 | 1.09 | $1,159,194 | $421,282 |
| 2021 | 475 | 32,222 | 77 | 1.17 | $1,095,052 | $410,121 |
| 2020 | 426 | 29,615 | 77 | 1.20 | $981,949 | $347,569 |
| 2019 | 484 | 35,059 | 77 | 1.32 | $1,160,282 | $400,514 |
| 2018 | 436 | 29,281 | 77 | 1.33 | $1,041,541 | $351,028 |
| 2017 | 407 | 23,134 | 77 | 1.32 | $1,041,975 | $353,441 |
| 2016 | 421 | 25,303 | 77 | 1.23 | $1,034,461 | $333,383 |
| 2015 | 391 | 18,664 | 77 | 1.25 | $995,463 | $326,988 |
| 2014 | 384 | 7,299 | 77 | 1.18 | $814,617 | $267,148 |
| 2013 | 418 | 5,303 | 77 | 1.24 | $778,031 | $269,306 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Return visit (30+ min) | 412 | $95,579 | $112 |
| Short return visit (20+ min) | 400 | $49,106 | $77 |
| Botox | 39 | $49,099 | None |
| Insertion of lower leg neurostimulator electrode | 29 | $32,558 | $123 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 37 | $29,114 | $393 |
| Diagnostic exam of bladder and urethra using an endoscope | 99 | $27,829 | $242 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 64 | $25,506 | $386 |
| Long return visit (40+ min) | 79 | $13,698 | $157 |
| New patient visit (45+ min) | 91 | $13,501 | $148 |
| Complete ultrasound scan behind abdominal cavity | 103 | $12,447 | $112 |
| Insertion of device into abdomen with pressure and urine flow rate study | 55 | $11,216 | $204 |
| Assessment of muscle signal of pelvic nerves | 53 | $7,746 | $146 |
| Ultrasound measurement of bladder capacity after voiding | 349 | $6,235 | $11 |
| Limited ultrasound scan of pelvis | 103 | $5,049 | $46 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 13 | $4,987 | $332 |
| New patient visit (30+ min) | 35 | $2,963 | $85 |
| Simple insertion of temporary bladder tube | 30 | $2,784 | $61 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $2,215 | $24 |
| Manual urinalysis test with examination using microscope, automated | 315 | $1,602 | $3 |
| Electronic assessment of bladder emptying | 134 | $1,532 | $10 |
| Simple bladder irrigation and/or instillation | 15 | $1,331 | $78 |
| Injection of drug or substance under skin or into muscle | 22 | $1,261 | $13 |
| Removal or manipulation of stone in ureter or kidney using an endoscope | 13 | $1,070 | $71 |
| Imaging of urinary tract following injection of a contrast agent | 15 | $398 | $22 |
2022: 26 services
| Return visit (30+ min) | 384 | $76,028 | $117 |
| Short return visit (20+ min) | 379 | $54,060 | $78 |
| Botox | 20 | $32,372 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 72 | $29,811 | $392 |
| Insertion of lower leg neurostimulator electrode | 23 | $22,558 | $125 |
| Diagnostic exam of bladder and urethra using an endoscope | 75 | $21,689 | $244 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 20 | $19,639 | $393 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 13 | $14,242 | None |
| New patient visit (45+ min) | 87 | $12,475 | $143 |
| Insertion of device into abdomen with pressure and urine flow rate study | 48 | $10,128 | $211 |
| Complete ultrasound scan behind abdominal cavity | 80 | $8,918 | $110 |
| Complicated insertion of bladder tube | 30 | $7,678 | $154 |
| Long return visit (40+ min) | 51 | $7,609 | $149 |
| Assessment of muscle signal of pelvic nerves | 47 | $6,890 | $147 |
| Ultrasound measurement of bladder capacity after voiding | 388 | $6,416 | $11 |
| Complete ultrasound scan of pelvis | 53 | $5,794 | $107 |
| New patient visit (30+ min) | 29 | $2,985 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,142 | $179 |
| Ultrasound scan of pelvic region through rectum | 13 | $1,972 | $152 |
| Manual urinalysis test with examination using microscope, automated | 390 | $1,910 | $3 |
| Electronic assessment of bladder emptying | 107 | $1,150 | $9 |
| Injection of drug or substance under skin or into muscle | 22 | $1,114 | $12 |
| Limited ultrasound scan of pelvis | 23 | $1,103 | $48 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 13 | $912 | $33 |
| Simple insertion of temporary bladder tube | 15 | $885 | $52 |
| Imaging of urinary tract following injection of a contrast agent | 11 | $293 | $23 |
2021: 24 services
| Short return visit (20+ min) | 331 | $53,961 | $82 |
| Return visit (30+ min) | 218 | $52,181 | $118 |
| Botox | 22 | $36,659 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 71 | $30,506 | $401 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 22 | $17,833 | $396 |
| Diagnostic exam of bladder and urethra using an endoscope | 60 | $17,751 | $237 |
| Insertion of lower leg neurostimulator electrode | 11 | $17,270 | $135 |
| New patient visit (45+ min) | 80 | $11,010 | $138 |
| Complete ultrasound scan behind abdominal cavity | 71 | $9,100 | $117 |
| Complicated insertion of bladder tube | 40 | $8,820 | $152 |
| Complete ultrasound scan of pelvis | 69 | $8,584 | $116 |
| Long return visit (40+ min) | 48 | $8,357 | $171 |
| Insertion of device into abdomen with pressure and urine flow rate study | 40 | $8,257 | $206 |
| Ultrasound measurement of bladder capacity after voiding | 309 | $6,375 | $11 |
| Assessment of muscle signal of pelvic nerves | 40 | $5,926 | $148 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 12 | $5,533 | $426 |
| New patient visit (30+ min) | 33 | $3,015 | $91 |
| Simple bladder irrigation and/or instillation | 11 | $2,246 | $80 |
| Ultrasound scan of pelvic region through rectum | 14 | $2,057 | $137 |
| Injection of drug or substance under skin or into muscle | 30 | $1,834 | $14 |
| Manual urinalysis test with examination using microscope, automated | 302 | $1,757 | $3 |
| Electronic assessment of bladder emptying | 87 | $846 | $8 |
| Removal or manipulation of stone in ureter or kidney using an endoscope | 11 | $656 | $55 |
| Imaging of urinary tract following injection of a contrast agent | 12 | $325 | $23 |
2020: 20 services
| Short return visit (20+ min) | 281 | $39,036 | $65 |
| Return visit (30+ min) | 182 | $38,990 | $98 |
| Botox | 18 | $27,634 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 70 | $26,871 | $368 |
| Insertion of lower leg neurostimulator electrode | 17 | $19,170 | $130 |
| Diagnostic exam of bladder and urethra using an endoscope | 60 | $17,047 | $208 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 18 | $12,063 | $366 |
| Complicated insertion of bladder tube | 32 | $9,293 | $137 |
| New patient visit (45+ min) | 65 | $8,830 | $136 |
| Complete ultrasound scan behind abdominal cavity | 63 | $7,190 | $106 |
| Complete ultrasound scan of pelvis | 58 | $6,998 | $111 |
| Insertion of device into abdomen with pressure and urine flow rate study | 38 | $6,542 | $172 |
| Long return visit (40+ min) | 44 | $6,028 | $134 |
| Assessment of muscle signal of pelvic nerves | 39 | $5,153 | $132 |
| Ultrasound measurement of bladder capacity after voiding | 235 | $4,505 | $10 |
| New patient visit (30+ min) | 34 | $2,705 | $80 |
| Ultrasound scan of pelvic region through rectum | 13 | $2,302 | $153 |
| Manual urinalysis test with examination using microscope, automated | 259 | $1,512 | $3 |
| Injection of drug or substance under skin or into muscle | 21 | $1,340 | $13 |
| Electronic assessment of bladder emptying | 84 | $890 | $9 |
2019: 21 services
| Return visit (30+ min) | 206 | $45,364 | $97 |
| Short return visit (20+ min) | 312 | $43,348 | $66 |
| Botox | 26 | $40,342 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 81 | $29,572 | $348 |
| Insertion of lower leg neurostimulator electrode | 18 | $25,129 | $130 |
| New patient visit (45+ min) | 117 | $17,009 | $145 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 27 | $16,591 | $325 |
| Diagnostic exam of bladder and urethra using an endoscope | 53 | $15,290 | $186 |
| Complicated insertion of bladder tube | 38 | $12,710 | $128 |
| Long return visit (40+ min) | 67 | $9,278 | $133 |
| Insertion of device into abdomen with pressure and urine flow rate study | 56 | $8,413 | $145 |
| Complete ultrasound scan behind abdominal cavity | 57 | $7,134 | $113 |
| Ultrasound measurement of bladder capacity after voiding | 291 | $7,096 | $13 |
| Assessment of muscle signal of pelvic nerves | 56 | $7,045 | $121 |
| Complete ultrasound scan of pelvis | 53 | $6,325 | $111 |
| New patient visit (30+ min) | 27 | $2,682 | $99 |
| Manual urinalysis test with examination using microscope, automated | 323 | $2,139 | $3 |
| Simple bladder irrigation and/or instillation | 11 | $1,860 | $74 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $1,528 | $22 |
| Injection of drug or substance under skin or into muscle | 20 | $1,463 | $16 |
| Electronic assessment of bladder emptying | 101 | $1,031 | $9 |
2018: 23 services
| Short return visit (20+ min) | 281 | $38,665 | $64 |
| Botox | 26 | $38,038 | None |
| Return visit (30+ min) | 186 | $36,578 | $98 |
| Insertion of lower leg neurostimulator electrode | 23 | $25,041 | $133 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 47 | $15,648 | $326 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 26 | $14,821 | $309 |
| Diagnostic exam of bladder and urethra using an endoscope | 67 | $13,851 | $163 |
| New patient visit (45+ min) | 90 | $12,863 | $143 |
| Complete ultrasound scan behind abdominal cavity | 56 | $7,867 | $114 |
| Long return visit (40+ min) | 55 | $7,703 | $128 |
| Complete ultrasound scan of pelvis | 53 | $7,368 | $113 |
| Ultrasound measurement of bladder capacity after voiding | 226 | $7,007 | $16 |
| Complicated insertion of bladder tube | 28 | $6,585 | $120 |
| Insertion of device into abdomen with pressure and urine flow rate study | 47 | $5,558 | $116 |
| Assessment of muscle signal of pelvic nerves | 47 | $5,312 | $111 |
| Manual urinalysis test with examination using microscope, automated | 295 | $2,192 | $4 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $1,711 | $22 |
| Injection of drug or substance under skin or into muscle | 25 | $1,709 | $20 |
| New patient visit (30+ min) | 14 | $1,219 | $87 |
| Ultrasound scan of pelvic region through rectum | 11 | $1,089 | $99 |
| Electronic assessment of bladder emptying | 83 | $970 | $10 |
| Injection, testosterone cypionate, 1 mg | 11 | $251 | None |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $6 | None |
2017: 22 services
| Short return visit (20+ min) | 258 | $38,134 | $65 |
| Return visit (30+ min) | 204 | $37,661 | $96 |
| Botox | 26 | $31,348 | None |
| Insertion of lower leg neurostimulator electrode | 21 | $30,961 | $130 |
| Destruction of prostate tissue using radiofrequency induced heat | 13 | $25,411 | $1,955 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 26 | $13,337 | $303 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 39 | $12,768 | $319 |
| Diagnostic exam of bladder and urethra using an endoscope | 60 | $11,534 | $160 |
| Complicated insertion of bladder tube | 40 | $10,930 | $119 |
| Ultrasound measurement of bladder capacity after voiding | 220 | $8,051 | $20 |
| New patient visit (45+ min) | 56 | $7,934 | $142 |
| Long return visit (40+ min) | 49 | $6,768 | $133 |
| Complete ultrasound scan behind abdominal cavity | 54 | $6,396 | $114 |
| Complete ultrasound scan of pelvis | 49 | $5,640 | $111 |
| Insertion of device into abdomen with pressure and urine flow rate study | 39 | $4,522 | $113 |
| Assessment of muscle signal of pelvic nerves | 39 | $4,346 | $109 |
| New patient visit (30+ min) | 34 | $3,153 | $93 |
| Manual urinalysis test with examination using microscope, automated | 305 | $2,488 | $4 |
| Ultrasound scan of pelvic region through rectum | 18 | $1,740 | $97 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $1,624 | $20 |
| Injection of drug or substance under skin or into muscle | 14 | $1,524 | $23 |
| Electronic assessment of bladder emptying | 74 | $987 | $11 |
2016: 23 services
| Return visit (30+ min) | 289 | $56,373 | $88 |
| Insertion of lower leg neurostimulator electrode | 25 | $32,899 | $123 |
| Botox | 27 | $32,188 | None |
| Short return visit (20+ min) | 161 | $19,925 | $64 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 52 | $15,476 | $298 |
| Diagnostic exam of bladder and urethra using an endoscope | 59 | $13,179 | $188 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 28 | $12,728 | $283 |
| New patient visit (45+ min) | 79 | $10,368 | $131 |
| Ultrasound measurement of bladder capacity after voiding | 237 | $7,552 | $18 |
| Complicated insertion of bladder tube | 38 | $7,428 | $118 |
| Long return visit (40+ min) | 54 | $6,774 | $121 |
| Insertion of device into abdomen with pressure and urine flow rate study | 52 | $5,480 | $105 |
| Assessment of muscle signal of pelvic nerves | 52 | $5,267 | $101 |
| Complete ultrasound scan behind abdominal cavity | 43 | $4,676 | $109 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 59 | $3,543 | $18 |
| Manual urinalysis test with examination using microscope, automated | 320 | $2,982 | $4 |
| Complete ultrasound scan of pelvis | 20 | $2,091 | $105 |
| Injection of drug or substance under skin or into muscle | 19 | $1,776 | $23 |
| Screening test for pathogenic organisms | 87 | $1,018 | $9 |
| Bacterial colony count, urine | 54 | $949 | $11 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 53 | $800 | $9 |
| Bacterial urine culture | 55 | $779 | $9 |
| Electronic assessment of bladder emptying | 79 | $758 | $9 |
2015: 26 services
| Return visit (30+ min) | 289 | $74,898 | $96 |
| Insertion of lower leg neurostimulator electrode | 30 | $37,381 | $123 |
| Botox | 27 | $27,956 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 59 | $18,940 | $316 |
| Diagnostic exam of bladder and urethra using an endoscope | 60 | $14,036 | $190 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 27 | $12,623 | $301 |
| New patient visit (45+ min) | 75 | $10,533 | $140 |
| Long return visit (40+ min) | 67 | $9,416 | $127 |
| Ultrasound measurement of bladder capacity after voiding | 248 | $8,831 | $19 |
| Short return visit (20+ min) | 79 | $8,560 | $62 |
| Insertion of device into abdomen with pressure and urine flow rate study | 58 | $6,605 | $112 |
| Assessment of muscle signal of pelvic nerves | 58 | $6,333 | $107 |
| Complicated insertion of bladder tube | 27 | $5,472 | $124 |
| Complete ultrasound scan behind abdominal cavity | 40 | $5,114 | $114 |
| Creation of sling around urethra in female to control leakage | 12 | $4,795 | $400 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 69 | $4,340 | $19 |
| Manual urinalysis test with examination using microscope, automated | 302 | $3,225 | $4 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,535 | $181 |
| Screening test for pathogenic organisms | 127 | $1,494 | $9 |
| Bacterial colony count, urine | 56 | $1,077 | $11 |
| Injection of drug or substance under skin or into muscle | 12 | $964 | $24 |
| Simple insertion of temporary bladder tube | 12 | $912 | $70 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 57 | $902 | $9 |
| Bacterial urine culture | 57 | $865 | $9 |
| Electronic assessment of bladder emptying | 72 | $704 | $9 |
| Cell examination of specimen, selective cellular enhancement technique | 13 | $531 | $35 |
2014: 26 services
| Return visit (30+ min) | 186 | $34,921 | $97 |
| Short return visit (20+ min) | 223 | $31,566 | $63 |
| Insertion of lower leg neurostimulator electrode | 26 | $27,527 | $117 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 55 | $16,672 | $292 |
| Botox | 15 | $12,949 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 48 | $11,404 | $170 |
| New patient visit (45+ min) | 70 | $9,689 | $138 |
| Complicated insertion of bladder tube | 39 | $9,388 | $116 |
| Ultrasound measurement of bladder capacity after voiding | 240 | $8,643 | $19 |
| Long return visit (40+ min) | 52 | $7,763 | $132 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 16 | $7,363 | $283 |
| Insertion of device into abdomen with pressure and urine flow rate study | 55 | $6,266 | $110 |
| Assessment of muscle signal of pelvic nerves | 54 | $6,117 | $109 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 55 | $5,356 | $94 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 57 | $3,471 | $18 |
| Complete ultrasound scan behind abdominal cavity | 26 | $3,322 | $119 |
| Manual urinalysis test with examination using microscope, automated | 287 | $2,995 | $4 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,863 | $169 |
| Injection of drug or substance under skin or into muscle | 29 | $1,643 | $23 |
| Screening test for pathogenic organisms | 98 | $1,304 | $9 |
| Simple bladder irrigation and/or instillation | 15 | $1,265 | $67 |
| Bacterial colony count, urine | 51 | $1,025 | $11 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 50 | $857 | $9 |
| Bacterial urine culture | 51 | $832 | $9 |
| Electronic assessment of bladder emptying | 65 | $646 | $9 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 24 | $290 | None |
2013: 27 services
| Insertion of lower leg neurostimulator electrode | 33 | $37,792 | $121 |
| Short return visit (20+ min) | 213 | $33,530 | $64 |
| Return visit (30+ min) | 168 | $25,385 | $97 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 60 | $17,790 | $296 |
| Complicated insertion of bladder tube | 43 | $11,920 | $116 |
| Diagnostic exam of bladder and urethra using an endoscope | 47 | $10,962 | $177 |
| Long return visit (40+ min) | 66 | $9,828 | $131 |
| New patient visit (45+ min) | 75 | $9,746 | $130 |
| Ultrasound measurement of bladder capacity after voiding | 225 | $7,821 | $20 |
| Assessment of muscle signal of pelvic nerves | 60 | $6,699 | $112 |
| Insertion of device into abdomen with pressure and urine flow rate study | 60 | $6,689 | $111 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 97 | $5,955 | $19 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 60 | $5,673 | $95 |
| Complete ultrasound scan behind abdominal cavity | 25 | $3,724 | $128 |
| Manual urinalysis test with examination using microscope, automated | 298 | $2,857 | $4 |
| New patient visit (60+ min) | 14 | $2,567 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,930 | $175 |
| Screening test for pathogenic organisms | 113 | $1,546 | $9 |
| Injection of drug or substance under skin or into muscle | 39 | $1,337 | $21 |
| Simple bladder irrigation and/or instillation | 13 | $1,278 | $75 |
| New patient visit (30+ min) | 12 | $1,109 | $92 |
| Bacterial colony count, urine | 60 | $1,012 | $10 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 60 | $846 | $9 |
| Bacterial urine culture | 60 | $822 | $8 |
| Complicated insertion of bladder tube | 11 | $744 | $68 |
| Electronic assessment of bladder emptying | 71 | $623 | $9 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 29 | $180 | None |
Medicaid work
$4 in 2024
Medicaid paid $4 for 90 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 90 | $4 |
| 2024 | 90 | 1 | 24 | $4 |
| 2023 | 265 | 4 | 20 | $76 |
| 2022 | 379 | 4 | 25 | $235 |
| 2021 | 476 | 4 | 28 | $233 |
| 2020 | 364 | 3 | 27 | $295 |
| 2019 | 670 | 4 | 25 | $840 |
| 2018 | 249 | 3 | 26 | $421 |
See the largest Medicaid services in earlier years
2023
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 74 | $39 |
| Short return visit (20+ min) | 80 | $26 |
| Return visit (30+ min) | 46 | $11 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 65 | $0 |
2022
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 89 | $118 |
| Short return visit (20+ min) | 132 | $106 |
| Return visit (30+ min) | 27 | $8 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 131 | $3 |
2021
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 90 | $164 |
| Short return visit (20+ min) | 180 | $65 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 180 | $3 |
| Return visit (30+ min) | 26 | $0 |
2020
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 49 | $210 |
| Short return visit (20+ min) | 165 | $84 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 150 | $1 |
2019
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 190 | $758 |
| Short return visit (20+ min) | 195 | $81 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 266 | $1 |
| Return visit (30+ min) | 19 | $0 |
2018
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 44 | $371 |
| Short return visit (20+ min) | 77 | $50 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 128 | $0 |
Drugs they prescribed that Part D paid
$304,493
Pharmacies billed $304,493 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (35 of 1,416) in 2024. Above the middle of the specialty; the typical urology clinician is at 2%.
1,163 generic and fewer than 11 brand-name prescriptions · $304,493 in drug cost · 449 antibiotic prescriptions to 230 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 185 | $186,814 | $1,010 |
| Myrbetriq | 43 | $45,995 | $1,070 |
| Estradiol | 54 | $4,870 | $90 |
| Tamsulosin | 269 | $3,065 | $11 |
| Testosterone | 13 | $2,437 | $187 |
See all 21 drugs
| Gemtesa | 185 | $186,814 | $1,010 |
| Myrbetriq | 43 | $45,995 | $1,070 |
| Estradiol | 54 | $4,870 | $90 |
| Tamsulosin | 269 | $3,065 | $11 |
| Testosterone | 13 | $2,437 | $187 |
| Finasteride | 174 | $2,420 | $14 |
| Methenamine Hippurate | 15 | $2,001 | $133 |
| Cephalexin | 199 | $1,933 | $10 |
| Oxybutynin Chloride Er | 45 | $1,526 | $34 |
| Fesoterodine Fumarate Er | 12 | $920 | $77 |
| Alfuzosin Hcl Er | 34 | $767 | $23 |
| Solifenacin | 14 | $731 | $52 |
| Nitrofurantoin Mono-Macro | 53 | $716 | $14 |
| Ciprofloxacin | 99 | $613 | $6 |
| Nitrofurantoin | 22 | $548 | $25 |
| Bicalutamide | 12 | $532 | $44 |
| Testosterone Cypionate | 12 | $518 | $43 |
| Hydrocodone-Acetaminophen | 35 | $294 | $8 |
| Amoxicillin-Clavulanate Potass | 19 | $144 | $8 |
| Sulfamethoxazole-Trimethoprim | 24 | $107 | $4 |
| Levofloxacin | 17 | $48 | $3 |
Year by year
| 2024 | 1,416 | 434 | 3% (35) | None | $304,493 |
| 2023 | 1,595 | 422 | 2% (28) | None | $305,391 |
| 2022 | 1,405 | 359 | 1% (17) | None | $201,544 |
| 2021 | 1,070 | 272 | 3% (28) | None | $139,056 |
| 2020 | 1,124 | 253 | 3% (28) | None | $254,872 |
| 2019 | 888 | 243 | 3% (25) | None | $96,872 |
| 2018 | 720 | 180 | 3% (23) | None | $153,194 |
| 2017 | 680 | 185 | 5% (31) | 24% | $80,495 |
| 2016 | 676 | 171 | 6% (37) | 27% | $76,273 |
| 2015 | 553 | 156 | 5% (26) | None | $59,677 |
| 2014 | 532 | 138 | 4% (21) | None | $54,014 |
| 2013 | 421 | 122 | 7% (29) | None | $32,124 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Gemtesa | 192 | $191,823 | $999 |
| Myrbetriq | 54 | $70,541 | $1,306 |
| Estradiol | 63 | $8,460 | $134 |
| Tamsulosin | 275 | $5,103 | $19 |
| Cephalexin | 254 | $4,817 | $19 |
| Oxybutynin Chloride Er | 67 | $3,402 | $51 |
| Finasteride | 193 | $3,220 | $17 |
| Alfuzosin Hcl Er | 37 | $1,491 | $40 |
| Nitrofurantoin | 29 | $1,366 | $47 |
| Nitrofurantoin Mono-Macro | 73 | $1,253 | $17 |
| Solifenacin | 19 | $1,232 | $65 |
| Fesoterodine Fumarate Er | 12 | $1,038 | $86 |
| Ciprofloxacin | 83 | $601 | $7 |
| Terazosin | 17 | $297 | $17 |
| Amoxicillin-Clavulanate Potass | 34 | $293 | $9 |
| Sulfamethoxazole-Trimethoprim | 37 | $252 | $7 |
| Hydrocodone-Acetaminophen | 27 | $228 | $8 |
| Fluconazole | 27 | $158 | $6 |
2022: 20 drugs
| Gemtesa | 131 | $99,361 | $758 |
| Myrbetriq | 56 | $44,673 | $798 |
| Toviaz | 21 | $9,546 | $455 |
| Estradiol | 67 | $9,187 | $137 |
| Oxybutynin Chloride Er | 88 | $5,165 | $59 |
| Nitrofurantoin | 41 | $3,703 | $90 |
| Tamsulosin | 241 | $3,689 | $15 |
| Imvexxy | 14 | $3,461 | $247 |
| Finasteride | 163 | $2,415 | $15 |
| Cephalexin | 171 | $1,591 | $9 |
| Solifenacin | 30 | $1,569 | $52 |
| Nitrofurantoin Mono-Macro | 64 | $1,491 | $23 |
| Ciprofloxacin | 103 | $626 | $6 |
| Alfuzosin Hcl Er | 13 | $508 | $39 |
| Terazosin | 15 | $266 | $18 |
| Amoxicillin-Clavulanate Potass | 15 | $175 | $12 |
| Hydrocodone-Acetaminophen | 17 | $162 | $10 |
| Fluconazole | 21 | $150 | $7 |
| Sulfamethoxazole-Trimethoprim | 21 | $110 | $5 |
| Levofloxacin | 18 | $83 | $5 |
2021: 16 drugs
| Myrbetriq | 74 | $58,361 | $789 |
| Oxybutynin Chloride Er | 134 | $7,476 | $56 |
| Toviaz | 14 | $7,316 | $523 |
| Estradiol | 39 | $6,599 | $169 |
| Imvexxy | 25 | $6,224 | $249 |
| Tamsulosin | 205 | $2,770 | $14 |
| Finasteride | 109 | $2,220 | $20 |
| Solifenacin | 28 | $1,932 | $69 |
| Nitrofurantoin | 20 | $1,619 | $81 |
| Nitrofurantoin Mono-Macro | 67 | $1,449 | $22 |
| Cephalexin | 88 | $862 | $10 |
| Ciprofloxacin | 68 | $449 | $7 |
| Terazosin | 16 | $326 | $20 |
| Hydrocodone-Acetaminophen | 26 | $234 | $9 |
| Sulfamethoxazole-Trimethoprim | 33 | $187 | $6 |
| Amoxicillin-Clavulanate Potass | 14 | $168 | $12 |
2020: 16 drugs
| Xtandi | 12 | $150,354 | $12,530 |
| Myrbetriq | 89 | $55,390 | $622 |
| Toviaz | 13 | $7,508 | $578 |
| Oxybutynin Chloride Er | 144 | $7,139 | $50 |
| Solifenacin | 45 | $5,782 | $128 |
| Estradiol | 27 | $5,532 | $205 |
| Tamsulosin | 222 | $2,634 | $12 |
| Finasteride | 126 | $2,064 | $16 |
| Nitrofurantoin Mono-Macro | 72 | $1,617 | $22 |
| Nitrofurantoin | 40 | $1,380 | $34 |
| Cephalexin | 63 | $870 | $14 |
| Oxybutynin Chloride | 12 | $837 | $70 |
| Ciprofloxacin | 53 | $292 | $6 |
| Levofloxacin | 22 | $221 | $10 |
| Hydrocodone-Acetaminophen | 27 | $206 | $8 |
| Sulfamethoxazole-Trimethoprim | 48 | $149 | $3 |
2019: 14 drugs
| Myrbetriq | 51 | $33,433 | $656 |
| Vesicare | 15 | $12,122 | $808 |
| Oxybutynin Chloride Er | 149 | $7,164 | $48 |
| Estradiol | 21 | $4,835 | $230 |
| Solifenacin | 20 | $3,018 | $151 |
| Tamsulosin | 170 | $2,443 | $14 |
| Nitrofurantoin Mono-Macro | 66 | $1,372 | $21 |
| Finasteride | 72 | $1,256 | $17 |
| Cephalexin | 71 | $835 | $12 |
| Ciprofloxacin | 46 | $296 | $6 |
| Nitrofurantoin | 12 | $262 | $22 |
| Sulfamethoxazole-Trimethoprim | 38 | $191 | $5 |
| Hydrocodone-Acetaminophen | 22 | $175 | $8 |
| Trospium Chloride | 11 | $91 | $8 |
2018: 13 drugs
| Vesicare | 37 | $22,765 | $615 |
| Myrbetriq | 29 | $17,752 | $612 |
| Oxybutynin Chloride Er | 86 | $4,444 | $52 |
| Tamsulosin | 168 | $2,858 | $17 |
| Estradiol | 12 | $2,801 | $233 |
| Nitrofurantoin Mono-Macro | 69 | $2,040 | $30 |
| Cephalexin | 68 | $787 | $12 |
| Oxybutynin Chloride | 13 | $681 | $52 |
| Finasteride | 28 | $527 | $19 |
| Trospium Chloride | 16 | $436 | $27 |
| Hydrocodone-Acetaminophen | 21 | $213 | $10 |
| Ciprofloxacin | 34 | $160 | $5 |
| Sulfamethoxazole-Trimethoprim | 34 | $142 | $4 |
2017: 12 drugs
| Myrbetriq | 53 | $27,411 | $517 |
| Vesicare | 62 | $26,917 | $434 |
| Tamsulosin | 142 | $2,657 | $19 |
| Oxybutynin Chloride Er | 56 | $2,421 | $43 |
| Nitrofurantoin Mono-Macro | 60 | $1,528 | $25 |
| Dutasteride-Tamsulosin | 13 | $1,389 | $107 |
| Cephalexin | 60 | $874 | $15 |
| Oxybutynin Chloride | 13 | $588 | $45 |
| Ciprofloxacin | 64 | $397 | $6 |
| Sulfamethoxazole-Trimethoprim | 38 | $192 | $5 |
| Oxycodone-Acetaminophen | 17 | $175 | $10 |
| Hydrocodone-Acetaminophen | 14 | $114 | $8 |
2016: 14 drugs
| Myrbetriq | 67 | $30,298 | $452 |
| Vesicare | 53 | $18,421 | $348 |
| Estrace | 14 | $3,729 | $266 |
| Tamsulosin | 143 | $3,484 | $24 |
| Oxybutynin Chloride Er | 56 | $2,288 | $41 |
| Jalyn | 12 | $1,969 | $164 |
| Dutasteride-Tamsulosin | 11 | $1,398 | $127 |
| Nitrofurantoin Mono-Macro | 30 | $827 | $28 |
| Ciprofloxacin | 62 | $485 | $8 |
| Finasteride | 36 | $479 | $13 |
| Cephalexin | 35 | $441 | $13 |
| Oxycodone-Acetaminophen | 35 | $342 | $10 |
| Bethanechol Chloride | 11 | $269 | $24 |
| Sulfamethoxazole-Trimethoprim | 25 | $136 | $5 |
2015: 16 drugs
| Myrbetriq | 26 | $12,652 | $487 |
| Vesicare | 26 | $9,829 | $378 |
| Estrace | 20 | $4,511 | $226 |
| Cialis | 14 | $3,640 | $260 |
| Oxybutynin Chloride Er | 58 | $3,526 | $61 |
| Jalyn | 22 | $3,515 | $160 |
| Tamsulosin | 94 | $2,607 | $28 |
| Oxybutynin Chloride | 18 | $621 | $34 |
| Nitrofurantoin Mono-Macro | 20 | $459 | $23 |
| Finasteride | 32 | $365 | $11 |
| Cephalexin | 30 | $322 | $11 |
| Bethanechol Chloride | 12 | $321 | $27 |
| Ciprofloxacin | 50 | $259 | $5 |
| Oxycodone-Acetaminophen | 21 | $209 | $10 |
| Levofloxacin | 14 | $131 | $9 |
| Sulfamethoxazole-Trimethoprim | 14 | $59 | $4 |
2014: 14 drugs
| Vesicare | 53 | $16,865 | $318 |
| Myrbetriq | 25 | $7,898 | $316 |
| Estrace | 30 | $4,914 | $164 |
| Jalyn | 23 | $3,263 | $142 |
| Oxybutynin Chloride Er | 44 | $2,592 | $59 |
| Vagifem | 16 | $2,203 | $138 |
| Tamsulosin | 58 | $1,326 | $23 |
| Nitrofurantoin Mono-Macro | 18 | $457 | $25 |
| Finasteride | 43 | $392 | $9 |
| Cephalexin | 26 | $263 | $10 |
| Ciprofloxacin | 49 | $214 | $4 |
| Oxycodone-Acetaminophen | 18 | $184 | $10 |
| Levofloxacin | 17 | $158 | $9 |
| Sulfamethoxazole-Trimethoprim | 18 | $70 | $4 |
2013: 10 drugs
| Vesicare | 65 | $15,630 | $240 |
| Myrbetriq | 16 | $3,930 | $246 |
| Oxybutynin Chloride Er | 53 | $3,670 | $69 |
| Estrace | 16 | $2,308 | $144 |
| Vagifem | 19 | $1,674 | $88 |
| Tamsulosin | 59 | $1,044 | $18 |
| Ciprofloxacin | 54 | $300 | $6 |
| Cephalexin | 18 | $157 | $9 |
| Oxycodone-Acetaminophen | 20 | $114 | $6 |
| Sulfamethoxazole-Trimethoprim | 21 | $70 | $3 |
Money from drug and device companies
$2,013 in 2025
| 2025 | 15 | 77 | None | $2,013 |
| 2024 | 12 | 27 | None | $711 |
| 2023 | 21 | 75 | None | $1,944 |
| 2022 | 22 | 74 | None | $1,884 |
| 2021 | 19 | 36 | None | $692 |
| 2020 | 19 | 45 | $900 | $1,684 |
| 2019 | 19 | 96 | $2,250 | $3,897 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sumitomo Pharma America | Gemtesa | $894 | 35 payments
|
| Abbvie | Botox | $217 | 9 payments
|
| Ferring Pharmaceuticals | Adstiladrin | $211 | 10 payments
|
| Coloplast | Titan | $172 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $98 | 4 payments
|
| Verity Pharmaceuticals | Tlando | $89 | 5 payments
|
See all 77 published payments
| Abbvie | Meals · 2025-12-19 | Botox | $28 |
| Sumitomo Pharma America | Meals · 2025-12-18 | Gemtesa | $34 |
| Verity Pharmaceuticals | Meals · 2025-12-16 | Tlando | $20 |
| Accord Healthcare | Meals · 2025-12-11 | Camcevi | $19 |
| Sumitomo Pharma America | Meals · 2025-12-04 | Gemtesa | $39 |
| Abbvie | Meals · 2025-12-04 | Lupron Depot | $18 |
| Coloplast | Meals · 2025-12-02 | Titan | $172 |
| Ferring Pharmaceuticals | Meals · 2025-11-25 | Adstiladrin | $20 |
| Novartis Pharmaceuticals | Meals · 2025-11-21 | Pluvicto | $34 |
| Progenics Pharmaceuticals | Meals · 2025-11-18 | Pylarify | $27 |
| Sumitomo Pharma America | Meals · 2025-11-13 | Gemtesa | $10 |
| Abbvie | Meals · 2025-11-13 | Botox | $23 |
| Ferring Pharmaceuticals | Meals · 2025-11-13 | Adstiladrin | $21 |
| Verity Pharmaceuticals | Meals · 2025-11-11 | Tlando | $16 |
| Sumitomo Pharma America | Meals · 2025-11-07 | Gemtesa | $34 |
| Pfizer | Meals · 2025-10-30 | Xtandi | $31 |
| Ferring Pharmaceuticals | Meals · 2025-10-23 | Adstiladrin | $19 |
| Sumitomo Pharma America | Meals · 2025-10-22 | Gemtesa | $39 |
| Verity Pharmaceuticals | Meals · 2025-10-16 | Trelstar | $18 |
| Sumitomo Pharma America | Meals · 2025-10-09 | Gemtesa | $5 |
| Sumitomo Pharma America | Meals · 2025-10-09 | Gemtesa | $5 |
| Sumitomo Pharma America | Meals · 2025-09-30 | Gemtesa | $36 |
| Ferring Pharmaceuticals | Meals · 2025-09-18 | Adstiladrin | $20 |
| Dendreon Pharmaceuticals | Meals · 2025-09-12 | Provenge | $26 |
| Sumitomo Pharma America | Meals · 2025-09-09 | Gemtesa | $9 |
| Sumitomo Pharma America | Meals · 2025-08-18 | Gemtesa | $32 |
| Astellas Pharma US | Meals · 2025-08-12 | Xtandi | $26 |
| Sumitomo Pharma America | Meals · 2025-08-06 | Orgovyx | $24 |
| Dendreon Pharmaceuticals | Meals · 2025-08-05 | Provenge | $16 |
| Abbvie | Meals · 2025-08-01 | Botox | $28 |
| Abbvie | Meals · 2025-08-01 | Lupron Depot | $4 |
| Sumitomo Pharma America | Meals · 2025-07-29 | Gemtesa | $34 |
| Ferring Pharmaceuticals | Meals · 2025-07-25 | Adstiladrin | $19 |
| Verity Pharmaceuticals | Meals · 2025-07-15 | Trelstar | $16 |
| Progenics Pharmaceuticals | Meals · 2025-07-10 | Pylarify | $22 |
| Sumitomo Pharma America | Meals · 2025-07-08 | Orgovyx | $26 |
| Sumitomo Pharma America | Meals · 2025-07-08 | Gemtesa | $39 |
| Sumitomo Pharma America | Meals · 2025-06-26 | Gemtesa | $20 |
| Sumitomo Pharma America | Meals · 2025-06-25 | Gemtesa | $20 |
| Sumitomo Pharma America | Meals · 2025-06-20 | Gemtesa | $29 |
| Ferring Pharmaceuticals | Meals · 2025-06-13 | Adstiladrin | $27 |
| Sumitomo Pharma America | Meals · 2025-06-05 | Gemtesa | $23 |
| Accord Healthcare | Meals · 2025-06-04 | Camcevi | $24 |
| Sumitomo Pharma America | Meals · 2025-06-02 | Gemtesa | $38 |
| Sumitomo Pharma America | Meals · 2025-05-30 | Orgovyx | $23 |
| Verity Pharmaceuticals | Meals · 2025-05-30 | Tlando | $18 |
| Progenics Pharmaceuticals | Meals · 2025-05-29 | Pylarify | $24 |
| Sumitomo Pharma America | Meals · 2025-05-21 | Gemtesa | $21 |
| Abbvie | Meals · 2025-05-21 | Botox | $27 |
| Sumitomo Pharma America | Meals · 2025-05-08 | Gemtesa | $41 |
| Sumitomo Pharma America | Meals · 2025-05-08 | Gemtesa | $39 |
| Astellas Pharma US | Meals · 2025-05-08 | Xtandi | $24 |
| Sumitomo Pharma America | Meals · 2025-05-07 | Gemtesa | $35 |
| Ferring Pharmaceuticals | Meals · 2025-05-02 | Adstiladrin | $29 |
| Sumitomo Pharma America | Meals · 2025-05-01 | Gemtesa | $38 |
| Abbvie | Meals · 2025-04-25 | Botox | $29 |
| Sumitomo Pharma America | Meals · 2025-04-24 | Gemtesa | $12 |
| Merck Sharp & Dohme | Meals · 2025-04-23 | Keytruda | $33 |
| Bluewind Medical | Meals · 2025-04-18 | Revi | $26 |
| Sumitomo Pharma America | Meals · 2025-04-15 | Gemtesa | $33 |
| Progenics Pharmaceuticals | Meals · 2025-04-15 | Pylarify | $24 |
| Sumitomo Pharma America | Meals · 2025-04-09 | Gemtesa | $8 |
| Pfizer | Meals · 2025-03-28 | Xtandi | $26 |
| Myriad Genetic Laboratories | Meals · 2025-03-26 | Myrisk | $25 |
| Sumitomo Pharma America | Meals · 2025-03-20 | Gemtesa | $11 |
| Ferring Pharmaceuticals | Meals · 2025-03-14 | Adstiladrin | $21 |
| Sumitomo Pharma America | Meals · 2025-03-12 | Gemtesa | $14 |
| Immunitybio | Meals · 2025-03-07 | Anktiva | $23 |
| Sumitomo Pharma America | Education · 2025-03-06 | Gemtesa | $5 |
| Sumitomo Pharma America | Meals · 2025-03-03 | Gemtesa | $34 |
| Abbvie | Meals · 2025-02-28 | Botox | $31 |
| Ferring Pharmaceuticals | Meals · 2025-02-27 | Adstiladrin | $5 |
| Sumitomo Pharma America | Meals · 2025-02-21 | Gemtesa | $18 |
| Ferring Pharmaceuticals | Meals · 2025-02-07 | Adstiladrin | $29 |
| Sumitomo Pharma America | Meals · 2025-02-06 | Gemtesa | $35 |
| Sumitomo Pharma America | Meals · 2025-01-29 | Gemtesa | $31 |
| Abbvie | Meals · 2025-01-10 | Botox | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $711
| Sumitomo Pharma America | Gemtesa | $400 | 14 payments
|
| Astellas Pharma US | Myrbetriq | $66 | 2 payments
|
| Abbvie | Lupron Depot | $42 | 2 payments
|
| Immunitybio | Anktiva | $34 | 1 payment
|
| Urogen Pharma | Jelmyto | $26 | 1 payment
|
| Verity Pharmaceuticals | Tlando | $24 | 1 payment
|
| Axonics | Axonics | $24 | 1 payment
|
| AngioDynamics | Nanoknife | $22 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $22 | 1 payment
|
| Medtronic | Interstim | $21 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $17 | 1 payment
|
| Biotissue Holdings | None | $15 | 1 payment
|
2023: $1,944
| Sumitomo Pharma America | Gemtesa | $655 | 23 payments
|
| Astellas Pharma US | Myrbetriq | $248 | 10 payments
|
| Abbvie | Botox | $157 | 8 payments
|
| Edap Technomed | None | $125 | 1 payment
|
| Agiliti Surgical | Sonablate | $78 | 1 payment
|
| Pfizer | Xtandi | $77 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $75 | 4 payments
|
| AngioDynamics | Nanoknife | $72 | 3 payments
|
| Myriad Genetic Laboratories | Myrisk | $64 | 3 payments
|
| Amgen | Xgeva | $58 | 2 payments
|
| Dendreon Pharmaceuticals | Provenge | $48 | 1 payment
|
| Janssen Biotech | Erleada | $45 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $39 | 2 payments
|
| 180 Medical | Cure Ultra Catheter | $39 | 2 payments
|
| Biotissue Holdings | Neox | $38 | 2 payments
|
| Coloplast | Titan | $28 | 1 payment
|
| Tolmar | Eligard | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $23 | 1 payment
|
| Medtronic | Interstim | $20 | 1 payment
|
| C. R. Bard Inc. & Subsidiaries | Bard Urinary Drainage Bag | $17 | 1 payment
|
| UroGen Pharma | None | $15 | 1 payment
|
2022: $1,884
| Urovant Sciences | Gemtesa | $552 | 23 payments
|
| Astellas Pharma US | Myrbetriq | $305 | 8 payments
|
| Abbvie | Lupron Depot | $194 | 8 payments
|
| Dendreon Pharmaceuticals | Provenge | $158 | 5 payments
|
| 180 Medical | Cure Catheter | $154 | 6 payments
|
| Myriad Genetic Laboratories | Prolaris | $72 | 3 payments
|
| Antares Pharma | Nocdurna | $47 | 2 payments
|
| Hollister | Infyna Chic | $43 | 2 payments
|
| Amgen | Prolia | $38 | 1 payment
|
| Teleflex | Urolift | $37 | 1 payment
|
| Janssen Biotech | Erleada | $36 | 2 payments
|
| Coloplast | Titan | $36 | 2 payments
|
| Endo Pharmaceuticals | Aveed | $35 | 2 payments
|
| Myovant Sciences | Orgovyx | $31 | 1 payment
|
| AngioDynamics | Nanoknife | $24 | 1 payment
|
| Olympus America | Itind System | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $22 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $20 | 1 payment
|
| Pfizer | Xtandi | $18 | 1 payment
|
| SRS Medical Systems | Urocuff | $15 | 1 payment
|
| Allergan | Botox | $14 | 1 payment
|
| UroGen Pharma | Jelmyto | $12 | 1 payment
|
2021: $692
| 180 Medical | Gentlecath | $89 | 3 payments
|
| Allergan | Botox | $80 | 5 payments
|
| AbbVie | Lupron Depot | $76 | 3 payments
|
| Urovant Sciences | Gemtesa | $65 | 3 payments
|
| Janssen Biotech | Erleada | $62 | 4 payments
|
| Coloplast | Titan | $47 | 3 payments
|
| Myovant Sciences | Orgovyx | $44 | 2 payments
|
| Boston Scientific | General Bph | $30 | 2 payments
|
| Amgen | Prolia | $25 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $23 | 1 payment
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $22 | 1 payment
|
| TherapeuticsMD | Imvexxy | $20 | 1 payment
|
| Clarus Therapeutics | Jatenzo | $16 | 1 payment
|
| Photocure | Cysview | $15 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $15 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $13 | 1 payment
|
| Axonics | Axonics R-Snm System | $12 | 1 payment
|
| Laborie Medical Technologies | None | $12 | 1 payment
|
2020: $1,684
| Intuitive Surgical | Da Vinci Surgical System | $900 | 1 payment
|
| 180 Medical | Gentlecath | $118 | 9 payments
|
| Pfizer | Xtandi | $96 | 5 payments
|
| Janssen Biotech | Erleada | $83 | 5 payments
|
| Astellas Pharma US | Xtandi | $78 | 4 payments
|
| Allergan | Botox | $73 | 4 payments
|
| Amgen | Prolia | $55 | 2 payments
|
| Travere Therapeutics | (815) Thiola | $40 | 2 payments
|
| Boston Scientific | General - Bph | $38 | 2 payments
|
| Coloplast | Penile & Testicular Reconstructn | $35 | 2 payments
|
| AbbVie | Lupron Depot | $25 | 1 payment
|
| Hollister | Vapro | $24 | 1 payment
|
| Dentsply Ih | Lofric | $21 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $20 | 1 payment
|
| Ferring Pharmaceuticals | Firmagon | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $19 | 1 payment
|
| NeoTract | Urolift | $16 | 1 payment
|
| Laborie Medical Technologies | None | $13 | 1 payment
|
| Axonics Modulation Technologies | Axonics R-Snm System | $12 | 1 payment
|
2019: $3,897
| Intuitive Surgical | Da Vinci Surgical System | $2,250 | 5 payments
|
| Allergan | Botox | $272 | 14 payments
|
| Astellas Pharma US | Xtandi | $260 | 18 payments
|
| Janssen Biotech | Erleada | $159 | 14 payments
|
| Pfizer | Xtandi | $149 | 11 payments
|
| Amgen | Prolia | $125 | 4 payments
|
| Dendreon Pharmaceuticals | Provenge | $113 | 4 payments
|
| Boston Scientific | General Bph | $98 | 5 payments
|
| C. R. Bard Inc. & Subsidiaries | None | $92 | 2 payments
|
| Ferring Pharmaceuticals | Firmagon | $67 | 3 payments
|
| Endo Pharmaceuticals | Xiaflex | $65 | 3 payments
|
| TherapeuticsMD | Imvexxy | $64 | 3 payments
|
| 180 Medical | Gentlecath | $38 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $36 | 2 payments
|
| Antares Pharma | Xyosted | $27 | 2 payments
|
| Retrophin | (815) Thiola | $26 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | None | $24 | 1 payment
|
| AbbVie | Lupron Depot | $20 | 1 payment
|
| Zyla Life Sciences | Zorvolex | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1962602151
- Licence
- CA A81674California A81674: Current · expires 2028-12-31
- Trained
- University of Michigan Medical School, 2001
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 2495 Hospital Dr Ste 425, Mountain View, CA, 94040
- NPI first listed
- 2007-07-25
- NPI last updated
- 2025-12-29
- NPI record certified
- 2025-12-29
This is when the NPI record was last certified, not a medical board exam.